Oncolix, currently developing a treatment for ovarian cancer, announced it has completed a reverse merger with Advanced Environmental Petroleum Producers.
Houston Methodist Hospital ranked No. 1 in Houston — and in Texas — for U.S. News & World Report’s 2017-18 rankings
Gregory Naeve, Ph.D., has been appointed as Chief Business Officer, effective August 21, of Bellicum Pharmaceuticals.
The idea is to help bridge the gap between healthcare-related ideas and the money those concepts need to become devices and medicines.
6,542,453 public offerings of common stock were closed, including 853,363 shares sold pursuant to the underwriters’ exercise of their option to purchase additional shares.
Acer plans to file a NDA for its lead product, EDSIVO™, for the treatment of vascular Ehlers-Danlos Syndrome (vEDS) in the first half of 2018
Texas Children’s overtakes its Boston rival in ascent that has been years in the making.
U.S. and E.U. data suggest favorable outcomes to alternative transplants for hematologic cancers and genetic blood diseases.